Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Home Diagnostics Touts Cost-Effective Testing for Diabetes Patients

Tue. August 11, 2009; Posted: 10:21 PM
Stocks RSS
Aug 11, 2009 (Close-Up Media via COMTEX) -- HDIX | Quote | Chart | News | PowerRating -- At the American Association of Diabetes Educators (AADE) 36th Annual Meeting, Home Diagnostics, Inc., a manufacturer and marketer of diabetes testing supplies, reported that it is making diabetes testing more affordable with its TRUE family of products.

As people continue to struggle to make ends meet, the Company noted, diabetes patients also face the recurring cost of testing supplies, including test strips and meters. As store branded glucose monitoring systems, Home Diagnostics said its TRUE family of products "costs significantly less than the national brands."

According to a CNN poll, one in three respondents said they had cut back on necessities such as food or medicine because of the economy. To provide affordable diabetes care products without sacrificing quality, retailers, including CVS, Rite Aid and Walgreens, partner with Home Diagnostics for their store branded diabetes testing supplies. Blood glucose monitoring products manufactured by Home Diagnostics can typically save people with diabetes up to $400 per year on diabetes supplies* in comparison to competitive products and are covered by Medicare, Medicaid and most third-party insurance providers.

The Company said that its diabetes testing supplies, including the world's smallest blood glucose meter, TRUE2go, offers technology at an affordable price. About the size of a quarter and small enough to fit in a pocket or purse, TRUE2go attaches to the top of a vial of test strips and offers patients the convenience of on-the-go testing to help them better manage their diabetes. TRUE2go also features no-coding technology and a small sample size that make it more convenient for diabetics to test their blood glucose levels more often, allowing for greater control of their glucose levels.

"The availability and affordability of high quality blood glucose monitoring supplies is crucial for diabetes patients. Unfortunately, the cost of diabetes testing supplies, combined with the financial strains of a recession, can force some patients to sacrifice their well-being by testing less frequently," said Joe Capper, president and CEO of Home Diagnostics. "At Home Diagnostics, we develop high quality, state-of-the-art products like TRUE2go that are comparable to name brands. Our products offer patients the best of both worlds - tremendous value without the need to sacrifice quality of care."

((Comments on this story may be sent to health@closeupmedia.com))

For full details for HDIX click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.